Common dietary emulsifiers promote metabolic disorders and intestinal microbiota dysbiosis in mice - Panyod, Suraphan; Wu, Wei-Kai; Chang, Chih-Ting; Wada, Naohisa; Ho, Han-Chen; Lo, Yi-Ling; Tsai, Sing-Ping; Chen, Rou-An; Huang, Huai-Syuan; Liu, Po-Yu; Chen, Yi-Hsun; Chuang, Hsiao-Li; et al. (Communications biology, 2024)
Keywords: 631/326/2565/2134; 64/60; 692/4020/2741/2135; 692/499; 692/699/317; Animals; Biomedical and Life Sciences; Carboxymethylcellulose; Carboxymethylcellulose Sodium; Digestive system; Diglycerides; Dysbacteriosis; Dysbiosis - chemically induced; Dysbiosis - microbiology; Emulsifiers; Emulsifying Agents; Esters; Fatty acids; Gastrointestinal Microbiome - drug effects; Gastrointestinal tract; Glucose metabolism; Homeostasis; Hyperglycemia; Hyperinsulinemia; Insulin Resistance; Intestinal microflora; Lecithin; Lecithins; Life Sciences; Lipid metabolism; Lipopolysaccharides; Male; Metabolic Diseases - chemically induced; Metabolic Diseases - etiology; Metabolic Diseases - metabolism; Metabolic Diseases - microbiology; Metabolic disorders; Metabolic syndrome; Mice; Mice, Inbred C57BL; Microbiota; Monoglycerides; Mucus; Population studies; Sucrose; Sucrose - administration & dosage; Sucrose - adverse effects; Sucrose - metabolism; Sucrose fatty acid esters